Background illustration for clinical trials search

Paid Clinical Trials Hialeah

Discover 1,924 paid clinical trials in Hialeah, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,924

The Miami "EMPIRE" Trial - Eradication of Metastatic Pancreatic Cancer With Immuno-Radiation

for

Metastatic Pancreatic Ductal Adenocarcinoma,

Location: Miami FL

Sponsor: Benjamin Spieler

Sex: All

Age: 18+

Code: NCT06843551

Phase2, Recruiting

Preoperative Comprehensive Geriatric Assessment (CGA) and Postoperative Delirium

for

CGA

Location: Miami FL

Sponsor: University of Miami

Sex: All

Age: 60+

Code: NCT07059585

Recruiting

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

for

Cognitive Dysfunction, Lewy Body Disease, Synucleinopathies,

Location: Aventura FL, Miami FL, Delray Beach FL, Atlantis FL,

Sponsor: Eli Lilly and Company

Sex: All

Age: 55 - 70+

Code: NCT07589595

Phase2, Recruiting

Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity

for

Primary Sjögren's Syndrome

Location: Miami FL, Hollywood FL, Tamarac FL, Jupiter FL,

Sponsor: Immunovant Sciences GmbH

Sex: All

Age: 18 - 70+

Code: NCT06979531

Phase2, Recruiting

Drug-Interaction Assessment of GSK3772701 in Healthy Male and Female Participants Aged 18 to 55 Years

for

Malaria, Falciparum

Location: Miami FL

Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 55

Code: NCT07670377

Phase1, Recruiting

Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors

for

Rectal Adenocarcinoma, Clinical Stage: Stage II (T3-4, N-),

Location: Miami FL, Allentown PA, Middletown NJ, Basking Ridge NJ,

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT04165772

Phase2, Recruiting

MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

for

Transthyretin Amyloidosis (ATTR) With Cardiomyopathy

Location: Weston FL, Jacksonville FL, Charleston SC, Atlanta GA,

Sponsor: Intellia Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT06128629

Phase3, Recruiting

A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)

for

HPV, Oropharynx Cancer, HPV-Related Carcinoma,

Location: Miami FL, Middletown NJ, Basking Ridge NJ, New York NY,

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT05307939

Phase2, Recruiting

Pembrolizumab, Olaparib, and Temozolomide for People With Glioma

for

Glioma

Location: Miami FL, Allentown PA, Middletown NJ, Basking Ridge NJ,

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT05188508

Phase2, Recruiting

Empathic Communication Skills (ECS) Training

for

Lung Cancer

Location: Miami FL, Chesapeake VA, Philadelphia PA, New York NY,

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18 - 70+

Code: NCT05456841

Recruiting

A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer

for

HPV-Related Squamous Cell Carcinoma

Location: Miami FL, Middletown NJ, Basking Ridge NJ, New York NY,

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT06563479

Phase3, Recruiting

Study of ALTO-101 in Patients With Schizophrenia

for

Schizophrenia, Cognitive Impairment

Location: Hollywood FL, Tampa FL, Snellville GA, Gaithersburg MD,

Sponsor: Alto Neuroscience

Sex: All

Age: 21 - 55

Code: NCT06502964

Phase2, Recruiting

To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL

for

Peripheral T Cell Lymphoma

Location: Pembroke Pines FL, Louisville KY, Houston TX,

Sponsor: Acrotech Biopharma Inc.

Sex: All

Age: 18+

Code: NCT06072131

Phase3, Recruiting

Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)

for

Core Binding Factor Acute Myeloid Leukemia

Location: Pembroke Pines FL, Seneca SC, Greenville SC, Easley SC,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 59

Code: NCT06917911

Phase2, Recruiting

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

for

Acute Myeloid Leukemia

Location: Pembroke Pines FL, Miami FL, Hollywood FL, Augusta GA,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06672146

Phase2, Recruiting

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

for

Myelodysplastic Syndrome

Location: Pembroke Pines FL, Miami FL, Gainesville FL, Albany GA,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06577441

Phase2, Recruiting

Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts

for

Cerebral Vasospasm, Aneurysmal Subarachnoid Hemorrhage (aSAH)

Location: Miami FL, Marietta GA, Lexington KY, Morgantown WV,

Sponsor: Vesalio

Sex: All

Age: 22+

Code: NCT06893588

Recruiting

A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

for

Myelodysplastic Syndrome, Anemia

Location: Tamarac FL, Atlanta GA, Nashville TN, Baytown TX,

Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT07422480

Phase3, Recruiting

Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

for

Advanced/Metastatic Non-Small Cell Lung Cancer,

Location: Coral Springs FL, Tamarac FL, Orlando FL,

Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07227298

Phase1, Phase2, Recruiting

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

for

Prostate Cancer

Location: Miami FL, Fort Myers FL, Orlando FL, Charleston SC,

Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18 - 70+

Code: NCT06855277

Phase3, Recruiting

Paid Clinical Trials Hialeah

Filter results

The Miami "EMPIRE" Trial - Eradication of Metastatic Pancreatic Cancer With Immuno-Radiation

Preoperative Comprehensive Geriatric Assessment (CGA) and Postoperative Delirium

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity

Drug-Interaction Assessment of GSK3772701 in Healthy Male and Female Participants Aged 18 to 55 Years

Interested in new trials?

Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors

MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)

Pembrolizumab, Olaparib, and Temozolomide for People With Glioma

Empathic Communication Skills (ECS) Training

A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer

Study of ALTO-101 in Patients With Schizophrenia

To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL

Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts

A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC